Hepatitis C, Determinants of Outcome of Compensated Hepatitis C Virus-Related Cirrhosis | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Determinants of Outcome of Compensated Hepatitis C Virus-Related Cirrhosis

table  1.   Baseline Characteristics of Interferon-Treated Patients and Untreated Patients

Treated Patients (n = 59) Untreated Patients (n = 44)

Age at diagnosis (y)* 55 ± 9 56 ± 14
Sex (M/F) 39/20 33/11
Transfusion (%) 63 55
IVDU (%)  8 18
Duration of HCV infectiondagger (yr)* 16 ± 9 18 ± 10
Hepatomegaly (%) 51 49
Splenomegaly (%) 20 32
BMI* 25 ± 4 25 ± 4
ALT (IU/L)* 108 ± 65 96 ± 68
AST (IU/L)* 83 ± 36 85 ± 64
GGT (IU/L)* 88 ± 71 84 ± 52
Alkaline phosphatase (IU/L)* 72 ± 28 70 ± 27
Prothrombin time (%)* 82 ± 13 77 ± 16
Bilirubin (mg/dL)* 0.93 ± 0.35 0.99 ± 0.53
Albumin (g/dL)* 3.9 ± 0.5 3.9 ± 0.5
Child-Pugh score: A (%) 95 87
B (%)  5 13
Platelets (109/L)* 142 ± 48 124 ± 49
AFP (µg/L)* 15 ± 27 25 ± 42
Anti-HBc + (%) 32 30
Genotype 1b (%) 48 48
Knodell score* 10 ± 2.5 10 ± 2.2

* Mean ± SD.
In patients with known risk factors.
Abbreviations: IVDU, iv drug use; BMI, body/mass index; AST, aspartate aminotransferase; GGT, gamma glutamyl transpeptidase; AFP, -fetoprotein; HBc, hepatitis B core.

Return To Article